Piramal Enterprises secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business and the simplification of its corporate structure, the company said in a regulatory filing. The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger on Tuesday as the markets will remain shut on Wednesday on the account Ganesh Chaturthi.
US debt crisis fuels de-dollarisation talk; may boost emerging markets: Puneet Pal
The growing U.S. debt and fiscal deficits are sparking de-dollarisation conversations, potentially benefiting emerging markets like India. While immediate outflows from U.S. bonds are limited,